Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianpi Kanggu Granules is a traditional Chinese medicine (TCM) herbal formulation. The name translates to "Strengthen the Spleen and Combat Bone" granules, indicating its intended use in TCM for invigorating spleen function and supporting bone health. While there is extensive literature on related formulas such as Jianpi Qinghua granules (for digestive disorders) and other "Jianpi" (spleen-invigorating) products, direct clinical trial or mechanistic data specific to "Jianpi Kanggu Granules" are limited in the provided sources. However, based on TCM principles and naming conventions, this product likely contains a combination of herbs traditionally used to address spleen deficiency and promote bone strength—potentially targeting conditions like osteoporosis or general bone weakness. The mechanism of action would be multi-targeted modulation of metabolic pathways involved in bone metabolism, immune regulation, and gastrointestinal function according to TCM theory.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jianpi Kanggu Granules.